STERIS’ (TSE:STE – Free Report) – Analysts at Cormark lowered their FY2025 earnings per share (EPS) estimates for shares of STERIS’ in a note issued to investors on Tuesday, November 5th. Cormark analyst B. Watson now expects that the company will post earnings of $0.94 per share for the year, down from their prior estimate of $1.02.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C$0.12 by C$0.02. The company had revenue of C$231.38 million for the quarter, compared to analysts’ expectations of C$226.20 million.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- 3 Warren Buffett Stocks to Buy Now
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Learn Technical Analysis Skills to Master the Stock Market
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Stock Dividend Cuts Happen Are You Ready?
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
